The U.S. Food and Drug administration approved Latuda (lurasidone) this week for treatment of adults with schizophrenia. Latuda is an atypical antipsychotic medication. From the FDA website: FDA approves Latuda to treat schizophrenia in adults The U.S. Food and Drug...
The Link Between Bipolar Disorders and Creativity: Evidence from Personality and Temperament Studies. Srivastava S, Ketter TA. Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 401 Quarry Road, Stanford, CA, 94305, USA,...